CalciMedica, Inc. — Director's Dealing 2023

May 18, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CalciMedica, Inc. (CALC)
CIK: 0001534133
Period of Report: 2023-05-16

Reporting Person: Hebbar Sudarshan (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-16	Common Stock	P	10000	$2.6999	Acquired	10000	Direct

Footnotes

F1: The weighted average purchase price for the transaction reported was $2.6999, and the range of prices were between $2.69 and $2.70. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.